Literature DB >> 16920230

Comparison of pertussis surveillance systems in Europe.

Alberto E Tozzi1, Elisabetta Pandolfi, Lucia Pastore Celentano, Marco Massari, Stefania Salmaso, Marta L Ciofi degli Atti.   

Abstract

We compared pertussis surveillance systems of 16 European countries in the period 1998-2002. In twelve out of sixteen countries the system covered the general population. Ten countries relied on WHO case definition for surveillance of pertussis. Eleven countries applied laboratory tests, and eight of them used PCR for case confirmation. The proportion of hospitalised rates in children<1 year varied between 33.1 and 100%, while case fatality in the same age group varied between 0 and 21.3 per 1000. The adoption of WHO case definition, standardisation of laboratory diagnosis, and integration of information on deaths from alternative sources should be supported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920230     DOI: 10.1016/j.vaccine.2006.07.023

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey-1945 to 2005.

Authors:  Irja Lutsar; Ioana Anca; Mustafa Bakir; Vytautas Usonis; Roman Prymula; Nuran Salman; Pawel Grezesiowski; Michael Greenberg
Journal:  Eur J Pediatr       Date:  2008-07-05       Impact factor: 3.183

2.  Incidence of whooping cough in Spain (1997-2010): an underreported disease.

Authors:  María Isabel Fernández-Cano; Lluís Armadans Gil; Xavi Martínez Gómez; Magda Campins Martí
Journal:  Eur J Pediatr       Date:  2013-12-11       Impact factor: 3.183

3.  Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries.

Authors:  Mirjam Kretzschmar; Peter F M Teunis; Richard G Pebody
Journal:  PLoS Med       Date:  2010-06-22       Impact factor: 11.069

4.  Pertussis serology: assessment of IgG anti-PT ELISA for replacement of the CHO cell assay.

Authors:  Tine Dalby; Charlotte Sørensen; Jesper Westphal Petersen; Karen Angeliki Krogfelt
Journal:  APMIS       Date:  2010-09-02       Impact factor: 3.205

5.  Bordetella pertussis in infants hospitalized for acute respiratory symptoms remains a concern.

Authors:  Ambra Nicolai; Raffaella Nenna; Paola Stefanelli; Anna Carannante; Concetta Schiavariello; Alessandra Pierangeli; Carolina Scagnolari; Corrado Moretti; Paola Papoff; Enea Bonci; Marianna Ferrara; Stefano Papasso; Fabio Midulla
Journal:  BMC Infect Dis       Date:  2013-11-08       Impact factor: 3.090

6.  Bordetella pertussis: an underreported pathogen in pediatric respiratory infections, a prospective cohort study.

Authors:  Gertrude van den Brink; Jérôme O Wishaupt; Jacob C Douma; Nico G Hartwig; Florens G A Versteegh
Journal:  BMC Infect Dis       Date:  2014-09-30       Impact factor: 3.090

7.  Infants hospitalized for Bordetella pertussis infection commonly have respiratory viral coinfections.

Authors:  A Frassanito; R Nenna; A Nicolai; A Pierangeli; A E Tozzi; P Stefanelli; R Carsetti; C Concato; I Schiavoni; F Midulla
Journal:  BMC Infect Dis       Date:  2017-07-12       Impact factor: 3.090

8.  Severe pertussis infection in infants less than 6 months of age: Clinical manifestations and molecular characterization.

Authors:  Paola Stefanelli; Gabriele Buttinelli; Paola Vacca; Alberto E Tozzi; Fabio Midulla; Rita Carsetti; Giorgio Fedele; Alberto Villani; Carlo Concato
Journal:  Hum Vaccin Immunother       Date:  2017-01-27       Impact factor: 3.452

9.  Geographical differences in whooping cough in Catalonia, Spain, from 1990 to 2010.

Authors:  Inma Crespo; Núria Soldevila; Pilar Muñoz; Pere Godoy; Gloria Carmona; Angela Domínguez
Journal:  BMC Public Health       Date:  2014-03-20       Impact factor: 3.295

10.  Pertussis in Italy: how to protect the "unprotectable"?

Authors:  Fabiana Fiasca; Stefano Necozione; Antonella Mattei
Journal:  Hum Vaccin Immunother       Date:  2020-10-29       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.